Sinha Vikas

Chief Financial Officer | See Remarks

2 companies

Insider Signal Score

Excellent

Trades Analyzed

12M Win Rate

97.4%

Avg 3M Return

+19.2%

Avg 12M Return

+60.5%

Sinha Vikas is a Chief Financial Officer at Scholar Rock Holding Corp with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.

Estimated insider holdings value: $27.3M based on current market prices.

Holdings by Company

SRRKJan 13, 2026

Current Shares583.2K

Value$27.09M

Net Activity-16,755

Bought: 0Sold: 16.8K

KLRSFeb 21, 2025

Current Shares49.1K

Value$253.0K

Net Activity-106,402

Bought: 0Sold: 106.4K

Transaction History

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 13, 2026	SRRK Scholar Rock Holding Corp	Chief Financial Officer	Sell	16,755	$42.70	$715,438.50	-2.8%	+14.2%	-
Feb 21, 2025	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	303	$10.08	$3,052.97	-0.6%	-70.6%	+3.8%
Jan 23, 2025	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	129	$9.50	$1,225.86	-0.1%	-31.2%	-3.8%
Jan 10, 2025	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	979	$0.44	$430.86	-	-27.6%	-3.2%
Nov 19, 2024	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	3,186	$0.55	$1,747.52	-0.3%	-25.6%	-48.1%
Nov 5, 2024	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	5,136	$0.86	$4,442.13	-0.4%	-57.0%	-78.0%
Oct 22, 2024	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	3,428	$0.77	$2,649.33	-0.1%	-47.6%	-75.5%
Oct 3, 2024	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	940	$0.81	$765.91	-	-45.0%	-64.7%
Aug 19, 2024	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	3,159	$0.76	$2,399.26	-0.3%	-24.6%	-85.4%
Aug 5, 2024	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	5,251	$0.73	$3,858.43	-0.5%	+21.3%	-84.8%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC